neuroendocrine carcinoma

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

Not yet recruiting
  • Neuroendocrine Carcinoma
  • Surufatinib and Serplulimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

Enrolling by invitation
  • Breast Cancer
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 18, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Dec 2, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

Recruiting
  • Neuroendocrine Tumor Grade 3
  • +2 more
  • Tianjin, Tianjin, China
    Rui Liu
Nov 17, 2022

Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • VSV-IFNβ-NIS
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic
Sep 26, 2022

Neuroendocrine Tumors - Patient Reported Outcomes

Enrolling by invitation
  • Neuroendocrine Tumors
  • +3 more
    • Gainesville, Florida
    • +13 more
    Jul 7, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Göttingen, Lower Saxony, Germany
    • +5 more
    Jun 27, 2022

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Lu-DOTA-TATE
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 5, 2022

    Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Aix-en-Provence, France
    • +6 more
    Mar 9, 2022

    Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston

    Recruiting
    • Lung Atypical Carcinoid Tumor
    • +13 more
    • Nivolumab
    • Stereotactic Body Radiation Therapy
    • Conroe, Texas
    • +2 more
    Feb 25, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)

    Recruiting
    • Neuroendocrine Tumors
    • +3 more
    • EUS guided radiofrequency ablation
    • Roma, RM, Italy
    • +1 more
    Feb 10, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Beijing, Beijing, China
    • +2 more
    Nov 2, 2021

    Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

    Recruiting
    • Lung Small Cell Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Neuroendocrine Carcinoma, Digestive Cancer Trial in France (Neoadjuvant treatment, Adjuvant treatment)

    Recruiting
    • Neuroendocrine Carcinoma
    • Digestive Cancer
    • Neoadjuvant treatment
    • Adjuvant treatment
    • Amiens, France
    • +13 more
    Jun 10, 2021

    Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)

    Completed
    • Neuroendocrine Carcinoma
    • Los Angeles, California
      University of California Los Angeles, Nuclear Medicine Clinic of
    May 12, 2021